College

N.g.s.m. Institute Of Pharmaceutical Sciences

  • Overall Grade: not available yet
  • University
  • Location: Dakshina Kannada, Karnataka
  • No reviews yetWrite a review
#51 in Pharmacy (Government of India – NIRF 2025)

Updated

See my chances

N.g.s.m. Institute Of Pharmaceutical Sciences Admissions & Acceptance

Admissions

Every published route into this institute runs on marks already earned. The B.Pharm page states that admission is based on merit in the qualifying examination, the Pharm.D page states the same, and the M.Pharm page states it for the postgraduate programme. None of the three names an entrance test, a state counselling authority or a national qualifying examination for pharmacy. What each of them does name is the same first step: submit the admission query form on the university's application portal at apply.nitte.edu.in, after which the admission section takes the candidate through registration.

ProgrammeQualifying bar
B.PharmClass 12 with at least 50% in aggregate in physics, chemistry and mathematics or biology, English among the languages studied, and 17 years of age as on 31 December of the admission year
B.Pharm, lateral entry to year twoD.Pharm with at least 45% in aggregate
Pharm.DThe same Class 12 bar as B.Pharm, or a D.Pharm from a PCI-approved institution
Pharm.D (Post Baccalaureate)B.Pharm with 50% from a PCI-approved institution, entering the fourth year
M.PharmB.Pharm from a recognised university with at least 55% in aggregate

Sources: the B.Pharm, Pharm.D, Pharm.D Post Baccalaureate and M.Pharm programme pages.

Two details in that table shape a real decision. A candidate who took mathematics rather than biology at Class 12 is eligible for both the B.Pharm and the Pharm.D, since the Pharm.D page accepts either subject, so the six-year clinical route is open to a physics, chemistry and mathematics student who never studied biology. And the 45% bar for lateral entry is lower than the 50% bar for direct entry, which makes the diploma route the softer academic door. That door does not depend on the institute's own diploma: the B.Pharm page sets the bar on the D.Pharm itself, not on where it was awarded.

The paperwork is heavier than the selection. The B.Pharm page lists originals plus two attested copies of the Class 10 and Class 12 marks cards and the transfer certificate, originals of the conduct certificate, the migration certificate, a physical fitness certificate from a registered medical practitioner and a blood group certificate, an Aadhaar copy, and photographs at 300 to 600 dpi in both passport and stamp sizes, five of each. Lateral entrants add their diploma marks cards, the diploma certificate and the pharmacist registration certificate issued by their State Pharmacy Council. The eligibility certificate is the one document the candidate does not chase, since the same page says Nitte handles it.

Teaching starts on a date the university fixes, generally in August, on the B.Pharm, Pharm.D and M.Pharm pages alike. The post-baccalaureate Pharm.D publishes eligibility but no selection method, and the Ph.D page publishes neither, giving only the mode and the duration. Ask about both routes directly rather than assuming they follow the merit rule stated for the other three.

Admissions Statistics

Seats

100

B.Pharm · PCI-approved intake · Course, approved for 2026-2027

Sanctioned (approved) intake

Academic yearUG [4 Years Program(s)]PG [2 Year Program(s)]PG [6 Years Program(s)]
2023-241009030
2022-231009030
2021-22100 Not published30
2020-21100 Not published30
2019-20 Not published Not published30
2018-19 Not published Not published30

First-year admissions

ProgrammeAcademic yearFirst-year intakeAdmitted
UG [4 Years Program(s)]2020-21100100
UG [4 Years Program(s)]2019-20100100
UG [4 Years Program(s)]2018-19100100
UG [4 Years Program(s)]2017-18 NIRF data 2024100100
UG [4 Years Program(s)]2016-17 NIRF data 2023100100
PG [2 Years Program(s)]2022-239075
PG [2 Years Program(s)]2021-229079
PG [2 Years Program(s)]2020-217567
PG [2 Years Program(s)]2019-20 NIRF data 20247558
PG [2 Years Program(s)]2018-19 NIRF data 20238457
PG [6 Years Program(s)]2018-193030
PG [6 Years Program(s)]2017-183030
PG [6 Years Program(s)]2016-173030
PG [6 Years Program(s)]2015-16 NIRF data 20243030
PG [6 Years Program(s)]2014-15 NIRF data 20233030

Admitted through lateral entry

ProgrammeAcademic yearLateral entry
UG [4 Years Program(s)]2021-221
UG [4 Years Program(s)]2020-218
UG [4 Years Program(s)]2019-201
UG [4 Years Program(s)]2018-19 NIRF data 20241
UG [4 Years Program(s)]2017-18 NIRF data 20231

Data source: NIRF data for Pharmacy only – data submitted for India Rankings 2025, 2024 and 2023

STUDENT POLLS


More opinions are needed to display this poll. Take our survey to add your opinion!

Cutoff

A cutoff is the residue of a ranked queue, and nothing this institute publishes describes one being formed. Its B.Pharm, Pharm.D and M.Pharm pages each select on merit in the qualifying examination and route applicants to Nitte's application portal; none of them names a test, a rank list or a counselling authority allotting the seats, and no closing position appears anywhere on the site.

The eligibility percentage is the nearest thing to a threshold. The 50% aggregate in physics, chemistry and mathematics or biology for B.Pharm and Pharm.D, the 45% for lateral entry and the 55% for M.Pharm are the only marks bars the institute states, and it does not publish where the last admitted candidate actually stood in any year. Treat any percentage circulating as this institute's cut-off as an estimate of a figure it has never released.

What can be checked instead is which courses actually fill, because the institute files sanctioned intake against admissions taken. Its 2025 ranking submission records 100 first-year B.Pharm admissions against 100 sanctioned places in each of the 2018-19, 2019-20 and 2020-21 intakes, and 30 against 30 on the six-year programme in each of 2016-17, 2017-18 and 2018-19. The master's is the one that does not close: the same document records 79 admissions against 90 sanctioned seats for 2021-22 and 75 against 90 for 2022-23. Demand here concentrates on the bachelor's and the six-year degree, and an M.Pharm applicant is queueing behind fewer people than the intake figure suggests.

Seat Matrix

The regulator's letter, not the prospectus, is where the seat count is settled, and the current one was communicated on 13 April 2026. The Pharmacy Council of India's decision letter for the 2026-2027 session approves each course separately, and every intake below is unchanged from the letter for 2024-2025 that preceded it.

Course, approved for 2026-2027 PCI-approved intake
B.Pharm 100
D.Pharm 60
Pharm.D 30
Pharm.D (Post Baccalaureate) 10
M.Pharm, Pharmaceutics 15
M.Pharm, Pharmacology 15
M.Pharm, Pharmaceutical Chemistry 15
M.Pharm, Pharmacy Practice 15
M.Pharm, Pharmaceutical Quality Assurance 15
M.Pharm, Regulatory Affairs 15
M.Pharm, Industrial Pharmacy 15

The earlier letter explains a discrepancy a careful reader will hit. The institute's M.Pharm page advertises 105 postgraduate seats, while the 2025 ranking submission records a sanctioned two-year postgraduate intake of 90 for both 2023-24 and 2022-23. In the 2024-2025 decision letter, taken at the Council's 412th Executive Committee meeting of 10 August 2024, only industrial pharmacy is marked "New institution, First time approval"; the other six M.Pharm branches carry no such note, and the extension wording is used for the bachelor's, the diploma and the two Pharm.D routes. The likeliest reconciliation is that the seventh branch of 15 seats postdates the ranking data rather than either count being wrong.

Two further points sit in the same filing, and one of them is a caution about the filing itself. The six-year programme has been sanctioned at 30 seats in every year from 2018-19 through 2023-24 without moving once, per the 2025 ranking submission, but its two tables disagree about the four-year programme: the sanctioned-intake table leaves 2018-19 and 2019-20 blank while the placement table records a first-year intake for both. Lateral entry, in the same document, has been a trickle rather than a channel, at 1 admission in 2019-20, 8 in 2020-21 and 1 in 2021-22.

Will You Get Into N.g.s.m. Institute Of Pharmaceutical Sciences?

Not available yet

Admissions Deadline & Due Dates

Not available yet

Admissions Requirements

Not available yet

Get recruited by colleges

Explore Admissions at Similar Colleges

How hard is it to get into N.g.s.m. Institute Of Pharmaceutical Sciences?

Not available yet

Reviews About Admissions

No reviews yet

Take our survey to add your review

Review N.g.s.m. Institute Of Pharmaceutical Sciences
Back to Full Profile